Founded in 2018, Asegua Therapeutics LLC is committed to providing greater access to therapies. Asegua Therapeutics LLC has launched an authorized generic of EPCLUSA® (sofosbuvir/velpatasvir) and an authorized generic of HARVONI® (ledipasvir/sofosbuvir).
Please see full Prescribing Information for sofosbuvir/velpatasvir and ledipasvir/sofosbuvir, including BOXED WARNING.